N. Katunuma et al., IMMUNOLOGICAL SIGNIFICANCES OF INVARIANT CHAIN FROM THE ASPECT OF ITSSTRUCTURAL HOMOLOGY WITH THE CYSTATIN FAMILY, FEBS letters, 349(2), 1994, pp. 265-269
The primary structure of p31 of invariant chain (Ii-chain) shows about
50% homology with those of the cystatin family which are endogenous c
ysteine protease inhibitors. The binding domains between Ii-chain and
HLA-DR-7 were estimated from the structural homology between cystatin
and Ii-chain and also between cathepsins and DR-7, respectively. The Q
L(64-71) and GS(76-88) of Ii-chain were estimated to be the binding do
mains with GG(45-51) and VS57-63 of HLA-DR7, respectively. The purifie
d human Ii-chain From spleen is capable of forming four molecular form
s from monomer to tetramer by redox-potential dependent disulfide bond
formation. The Ii-chain inhibits cathepsin L and H competitively as a
dimer and the K-i value for cathepsin L was 4.1 x 10(-8) M, but cathe
psin B was not inhibited at all. The Ii-chain showed mainly a dimer (6
0 kDa) under the assay condition of cathepsins with cysteine and was n
ot degraded by these cathepsins. The Ii-chain may play an important ro
le in the regulation of antigenic peptide presentation to MHC class II
.